Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Possis takes more powerful clot-removing catheter to the US:

This article was originally published in Clinica

Executive Summary

Possis Medical has released for sale in the US a version of its AngioJet thrombectomy catheter that can provide over twice the clot-removing power of its 4 French XMI and previous Spiroflex catheters. The device, called Spiroflex VG, is also the first AngioJet catheter of its size to be offered in a rapid exchange platform. It is available in the US for peripheral use only, though the Minneapolis, Minnesota firm plans to submit to the FDA a marketing application for coronary use in the coming weeks. Elsewhere, European CE- mark approval for the coronary and peripheral indications are pending.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel